Visualitzant - Articles científics per títol

IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer

Hack, Stephen; Verret, Wendy; Mulla, Sohail; Liu, Bo; Wang, Yulei; Macarulla Mercadé, Teresa (SAGE Publications, 2021-07-31)

Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment

Rubio Pérez, Carlota; Planas Rigol, Ester; Trincado, Juan L.; Bonfill Teixidor, Ester; Arias Piñeiro, Alexandra; Marchese, Domenica; Iurlaro, Raffaella; Martínez Ricarte, Francisco Ramón; Escudero Monreal, Laura; Cordero Asanza, Esteban Xavier; Cicuendez López Ocaña, Marta; Nuciforo, Paolo Giovanni; Sahuquillo Barris, Joan; Tabernero Caturla, Josep; Seoane Suarez, Joan; Serna, Garazi (Nature Research, 2021-03-08)

Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries

Cortellini, Alessio; Dettorre, Gino M; Dafni, U.; Aguilar Company, Juan; Castelo-Branco, L.; Lambertini, Matteo (BMJ, 2022-11)

Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer

Griguolo, Gaia; Pascual, Tomás; Fasani, Roberta; Chic, N.; Antunes de Melo Oliveira, Ana Mafalda; Nuciforo, Paolo Giovanni; Serna, Garazi; Guardia, Xavier (Nature Research, 2021-03-19)

Immune reactivity to Trypanosoma cruzi chimeric proteins for Chagas disease diagnosis in immigrants living in a non-endemic setting

Dopico, Eva; Pimenta del Rei, Rodrigo; Espinoza, Bertha; Ubillos, Itziar; Zanchin, Nilson Ivo Tonin; Sulleiro Igual, Elena; Moure Garcia, Zaira (BMC, 2019-03-12)

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

García-Pérez, Javier; González Pérez, Maria; Castillo de la Osa, María; Borobia, Alberto M.; Bertrán, María Jesús; Fuentes Camps, Inmaculada; Agustí Escasany, Maria Antònia; Campins Martí, Magda; Castaño, Luis (Elsevier, 2022-08)

Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions

Cohen, Jeffrey A; Bermel, Robert; Grossman, Cynthia; Hersh, Carrie; Hyland, Megan; Mowry, Ellen; Tintore Subirana, Mar; Zabalza de Torres, Ana; Montalban Gairín, Xavier (SAGE Publications, 2022-06)

Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer

Vrede, S. W.; van Weelden, Willem Jan; Visser, N. C. M.; van der Putten, L. J. M.; Van de Vijver, Koen; Colas Ortega, Eva; Gil Moreno, Antonio; Moiola, Cristian Pablo; Bulten, Johan (Elsevier, 2021-06)

Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia

Jiménez Bernal, Isabel; Tazón Vega, Bárbara; Abrisqueta Costa, Pablo; Nieto Sáchica, Juan Camilo; Bobillo Varela, Sabela; Palacio García, Carlos; Carabia Juberó, Júlia; Munuera Codina, Magdalena; Puigdefabregas Horta, Lluis; Franco Jarava, Clara; Iacoboni García-Calvo, Gloria; Crespo Maull, Marta; Bosch Albareda, Francesc (BMC, 2021-05-20)

Immunological, Clinical, and Epidemiological Features of Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection

Restrepo Vera, Juan Luis ; Palasi Franco, Antonio; González-Martínez, Victoria; Gratacòs-Viñola, Margarida; Salvadó Figueras, Maria; Llaurado, Arnau; Sánchez-Tejerina, Daniel; Sotoca, Javier; Raguer, Núria; Juntas Morales, Raúl (Hindawi, 2023)

Immunomodulatory Effects Associated with Cladribine Treatment

Calvo Barreiro, Laura; Eixarch Ahufinger, Herena; Boschert, Ursula; Espejo Ruiz, Carmen; Montalban Gairín, Xavier; Comabella Lopez, Manuel; Fissolo, Nicolás Miguel (MDPI, 2021-12)

Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled Trials

Arteaga Henriquez, Gara; Gisbert Gustemps, Laura; Ramos Quiroga, José Antonio (Adis, 2023-03)

Immunosenescence in multiple sclerosis: the identification of new therapeutic targets

Dema Etxezarreta, Maria Arantza; Eixarch Ahufinger, Herena; Montalban Gairín, Xavier; Espejo Ruiz, Carmen; Villar, Luisa M (Elsevier, 2021-09)

Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)

Girardin, François R; Nicolet, Anna; Bestard, Oriol; lefaucheur, carmen; Budde, Klemens; Halleck, Fabian (Frontiers Media, 2023-04-27)

Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?

Bermejo Garcia, Sheila; Bolufer Cardona, Monica; Riveiro Barciela, Maria del Mar; Soler Romeo, Maria Jose (Frontiers Media, 2022-06-14)

Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers

Ros, Javier; Baraibar, Iosune; Saoudi Gonzalez, Nadia; R Castells, Marta; Salvà, Francesc; Tabernero, Josep; Elez, Elena (MDPI, 2023-08-24)

Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol

Lehnert, Thomas; Röver, Christian; Köpke, Sascha; Rio Izquierdo, Jordi; Fittipaldo, Andrea Veronica; Chard, Declan (BMC, 2022-07-01)

Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study

Abtahi, Shahab; Pajouheshnia, Romin; Durán, Carlos E.; Riera-Arnau, Judit; Gamba, Magdalena; Alsina, Ema; Ibáñez, Luisa (Springer, 2023-07)

Impact of a system to assist in clinical decision-making in primary healthcare in Catalonia: prescription Self Audit

Pons‑Mesquida, M. Àngels; Oms Arias, Míriam; Figueras, Albert; Diogène Fadini, Eduard (BMC, 2022-03-19)

Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain

Gonzalez-Juanatey, Carlos; Anguita-Sánchez, Manuel; barrios, vivencio; Garcia-Moll, Xavier; Nuñez Gil, Ivan Javier; Gomez Doblas, Juan Jose; Soriano Colomé, Toni (MDPI, 2023-08-10)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant HVH - Articles científics per títol

IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer

Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment

Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries

Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer

Immune reactivity to Trypanosoma cruzi chimeric proteins for Chagas disease diagnosis in immigrants living in a non-endemic setting

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions

Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer

Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia

Immunological, Clinical, and Epidemiological Features of Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection

Immunomodulatory Effects Associated with Cladribine Treatment

Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled Trials

Immunosenescence in multiple sclerosis: the identification of new therapeutic targets

Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)

Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?

Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers

Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol

Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study

Impact of a system to assist in clinical decision-making in primary healthcare in Catalonia: prescription Self Audit

Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant HVH - Articles científics per títol

IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer ﻿

Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment ﻿

Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries ﻿

Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer ﻿

Immune reactivity to Trypanosoma cruzi chimeric proteins for Chagas disease diagnosis in immigrants living in a non-endemic setting ﻿

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study ﻿

Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions ﻿

Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer ﻿

Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia ﻿

Immunological, Clinical, and Epidemiological Features of Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection ﻿

Immunomodulatory Effects Associated with Cladribine Treatment ﻿

Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled Trials ﻿

Immunosenescence in multiple sclerosis: the identification of new therapeutic targets ﻿

Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN) ﻿

Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment? ﻿

Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers ﻿

Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol ﻿

Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study ﻿

Impact of a system to assist in clinical decision-making in primary healthcare in Catalonia: prescription Self Audit ﻿

Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer

Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment

Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries

Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer

Immune reactivity to Trypanosoma cruzi chimeric proteins for Chagas disease diagnosis in immigrants living in a non-endemic setting

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions

Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer

Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia

Immunological, Clinical, and Epidemiological Features of Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection

Immunomodulatory Effects Associated with Cladribine Treatment

Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled Trials

Immunosenescence in multiple sclerosis: the identification of new therapeutic targets

Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)

Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?

Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers

Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol

Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study

Impact of a system to assist in clinical decision-making in primary healthcare in Catalonia: prescription Self Audit

Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain